Fecal carriage of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in healthy children

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1261-1262

  Gurnee, Emily A ^a   Ndao, I Malick ^a   McGhee, Jessica E ^a   Warner, Barbara B ^a   Tarr, Phillip I ^a   Fritz, Stephanie A ^a   Burnham, Carey Ann D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPICILLIN; AZTREONAM; OXACILLIN; VANCOMYCIN;

CELL CULTURE; FECES; HUMAN; INCUBATION TEMPERATURE; INCUBATION TIME; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; CHILD; ENTEROCOCCUS; FECES; FEMALE; HUMANS; METHICILLIN RESISTANCE; MOTHERS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 84893471533     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02466-13     Document Type: Letter

References (10)

1. Klein EY, Sun L, Smith DL, Laxminarayan R. 2013. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. Am. J. Epidemiol. 177:666-674. http://dx.doi.org/10.1093/aje/kws273.
2. De Angelis G, Murthy A, Beyersmann J, Harbarth S. 2010. Estimating the impact of healthcare-associated infections on length of stay and costs. Clin. Microbiol. Infect. 16:1729-1735. http://dx.doi.org/10.1111/j.1469-0691.2010. 03332.x.
3. Eckmann C, Dryden M. 2010. Treatment of complicated skin and softtissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin. Eur. J. Med. Res. 15:554-563. http://dx.doi.org/10. 1186/2047-783X-15-12-554.
4. Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE. 2012. Unmet needs and prospects for oritavancin in the management of vancomycinresistant enterococcal infections. Clin. Infect. Dis. 54(Suppl 3):S233-S238. http://dx.doi.org/10.1093/cid/cir924.
5. CLSI. 2013. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia L, Westblade LF, Ferraro MJ, Branda JA. 2013. Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria. J. Clin. Microbiol. 51:2225-2231. http://dx.doi.org/10.1128/JCM.00682-13.
7. Faden H, Lesse AJ, Trask J, Hill JA, Hess DJ, Dryja D, Lee YH. 2010. Importance of colonization site in the current epidemic of staphylococcal skin abscesses. Pediatrics 125:e618-e624. http://dx.doi.org/10.1542/peds.2009-1523.
8. Henning KJ, Delencastre H, Eagan J, Boone N, Brown A, Chung M, Wollner N, Armstrong D. 1996. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr. Infect. Dis. J. 15:848-854. http://dx.doi.org/10.1097/00006454- 199610000-00004.
9. Singh-Naz N, Sleemi A, Pikis A, Patel KM, Campos JM. 1999. Vancomycin-resistant Enterococcus faecium colonization in children. J. Clin. Microbiol. 37:413-416.
10. Denno DM, Shaikh N, Stapp JR, Qin X, Hutter CM, Hoffman V, Mooney JC, Wood KM, Stevens HJ, Jones R, Tarr PI, Klein EJ. 2012. Diarrhea etiology in a pediatric emergency department: a case control study. Clin. Infect. Dis. 55:897-904. http://dx.doi.org/10.1093/cid/cis553.